Johnson & Johnson Innovative Medicine at Festival of Biologics 2026
Oct 13–15, 2026 Basel, Switzerland ~3k attendees Website
Johnson & Johnson Innovative Medicine takes part in 3 sessions at Festival of Biologics 2026 in Basel. Its program centres on formulation, the recipe that keeps a protein drug stable and usable from clinical studies to commercial products. Topics include rethinking how biologics formulations are developed and analysing excipients, the inactive ingredients, in protein and cell and gene therapy products.
| Organization | Festival of Biologics 2026 Attendance |
|---|---|
Johnson & Johnson Innovative Medicine New Brunswick, NJ | |
The pharmaceutical business of Johnson & Johnson, formerly Janssen. | Talk Tue Oct 13 17:50 Rethinking Formulation Development of Biologics Why formulating a biologic should follow the drug from design into the body, rather than stopping at shelf stability in a vial. Talk Thu Oct 15 12:40 |
Instantly find 20 buyers from Johnson & Johnson Innovative Medicine
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Terrapinn or the Festival of Biologics. Submit a correction